A pilot study to evaluate of the impact on bone density during treatment with mycophenolate mofetil, daclizumab in combination with ciclosporin converted to sirolimus with steroid as mainstay immunosuppression, in comparison to current standard immunosuppression (daclizumab, mycophenolate, ciclosporin and corticosteroids) in renal transplantation.
Phase of Trial: Phase III
Latest Information Update: 03 Aug 2015
At a glance
- Drugs Sirolimus (Primary) ; Ciclosporin; Corticosteroids; Daclizumab; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Adverse reactions
- 12 Aug 2011 New trial record